Correction – October 8

A story in the Oct. 6 edition (“Expanding Again,” A1) contained incorrect information. Elanco Animal Health is acquiring eight vaccine product lines and a manufacturing, research and development site from Boehringer Ingelheim International. Elanco has no plans to acquire Merial.